Clinical Trial Update: Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study evaluating the effect of ISIS 681257 on warfarin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hyperlipoproteinemia Elevation

Drugs mentioned

• ISIS 681257
• Warfarin (warfarin)

Snippet

Sponsor: Akcea Therapeutics | Conditions: Elevated Lipoprotein(a), Cardiovascular Diseases | Phase 1 | Status: COMPLETED